NZ215820A - Hepatitis b antigen formed by recombinant dna techniques - Google Patents

Hepatitis b antigen formed by recombinant dna techniques

Info

Publication number
NZ215820A
NZ215820A NZ215820A NZ21582086A NZ215820A NZ 215820 A NZ215820 A NZ 215820A NZ 215820 A NZ215820 A NZ 215820A NZ 21582086 A NZ21582086 A NZ 21582086A NZ 215820 A NZ215820 A NZ 215820A
Authority
NZ
New Zealand
Prior art keywords
hepatitis
recombinant dna
dna techniques
antigen formed
antigen
Prior art date
Application number
NZ215820A
Inventor
J S Salstrom
M L Rohrbaugh
H Thoma
Original Assignee
Endotronics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Endotronics Inc filed Critical Endotronics Inc
Publication of NZ215820A publication Critical patent/NZ215820A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/61Growth hormone [GH], i.e. somatotropin
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/576Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
    • G01N33/5761Hepatitis B
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/576Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
    • G01N33/5761Hepatitis B
    • G01N33/5764Hepatitis B surface antigen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00Reverse transcribing DNA viruses
    • C12N2730/00011Details
    • C12N2730/10011Hepadnaviridae
    • C12N2730/10111Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10122New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/52Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Communicable Diseases (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Food Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Endocrinology (AREA)
  • Pathology (AREA)
  • General Engineering & Computer Science (AREA)
  • Plant Pathology (AREA)
  • Virology (AREA)
  • Toxicology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
NZ215820A 1985-04-15 1986-04-14 Hepatitis b antigen formed by recombinant dna techniques NZ215820A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP85104521 1985-04-15
US85056786A 1986-04-11 1986-04-11

Publications (1)

Publication Number Publication Date
NZ215820A true NZ215820A (en) 1989-01-06

Family

ID=26096680

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ215820A NZ215820A (en) 1985-04-15 1986-04-14 Hepatitis b antigen formed by recombinant dna techniques

Country Status (9)

Country Link
KR (1) KR960004264B1 (en)
AU (1) AU606574B2 (en)
DK (1) DK171386A (en)
FI (1) FI95045C (en)
HU (1) HUT40699A (en)
NO (1) NO861450L (en)
NZ (1) NZ215820A (en)
OA (1) OA08238A (en)
PT (1) PT82392B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU619753B2 (en) * 1987-06-22 1992-02-06 Medeva Holdings B.V. Hepatitis b surface antigen vaccine

Also Published As

Publication number Publication date
AU5611486A (en) 1986-10-23
KR860008284A (en) 1986-11-14
OA08238A (en) 1987-10-30
DK171386D0 (en) 1986-04-15
PT82392A (en) 1986-05-01
HUT40699A (en) 1987-01-28
KR960004264B1 (en) 1996-03-30
FI861559A (en) 1986-10-16
DK171386A (en) 1986-10-16
FI861559A0 (en) 1986-04-14
FI95045B (en) 1995-08-31
AU606574B2 (en) 1991-02-14
PT82392B (en) 1988-03-03
NO861450L (en) 1986-10-16
FI95045C (en) 1995-12-11

Similar Documents

Publication Publication Date Title
IL78472A0 (en) Hepatitis b surface antigen formed by recombinant dna techniques,vaccines,diagnostics,cell lines and methods of forming same
DK112586D0 (en) Viral DNA
HK38293A (en) Hepatitis c virus
GB2181433B (en) Protein modification with peg
IL88175A0 (en) Human immunoglobulins produced by recombinant dna techniques
GB8628313D0 (en) Dna rna peptides/polypeptides
SG102092G (en) Hepatitis c virus
GB2068971B (en) Recombinant dna techniques
GB8404378D0 (en) Dna sequence recombinant dna molecules
GB8500918D0 (en) Viral isolates
GB8505487D0 (en) Antibodies
GB8815135D0 (en) Proteins & nucleic acids
KR880700074A (en) Gastric rabies virus protein
GB8526096D0 (en) Microcarrier
GB8506373D0 (en) Antigens antibodies
IL79740A0 (en) Hepatitis vaccine
NZ215820A (en) Hepatitis b antigen formed by recombinant dna techniques
IL79880A0 (en) Recombinant virus
IE852110L (en) Recombinant hepatitis antigen
IL61952A0 (en) Recombinant dna techniques
GB8500007D0 (en) Proteins
GB8412158D0 (en) Recombinant dna derived antigens
GB8623925D0 (en) Recombinant dna methods
GB8704278D0 (en) Labelled hepatitis b antibody
GB8621578D0 (en) Hepatitis b viral antigens